Advanced

Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion

Aguilar, Maria I.; Hart, Robert G.; Kase, Carlos S.; Freeman, William D.; Hoeben, Maj Barbara J.; Garcia, Rosa C.; Ansell, Jack E.; Mayer, Stephan A.; Norrving, Bo LU and Rosand, Jonathan, et al. (2007) In Mayo Clinic Proceedings 82(1). p.82-92
Abstract
Wider use of oral anticoagulants has led to an increasing frequency of warfarin-related intracerebral hemorrhage (ICH). The high early mortality of approximately 50% has remained stable in recent decades. In contrast to spontaneous ICH, the duration of bleeding is, 12 to 24 hours in many patients, offering a longer opportunity for Intervention. Treatment varies widely, and optimal therapy has yet to be defined. An OVID search was conducted from January 1996 to January 2006, combining the terms warfarin or anticoagulation with intracranial hemorrhage or intracerebral hemorrhage. Seven experts on clinical stroke, neurologic intensive care, and hematology were provided with the available information and were asked to independently address 3... (More)
Wider use of oral anticoagulants has led to an increasing frequency of warfarin-related intracerebral hemorrhage (ICH). The high early mortality of approximately 50% has remained stable in recent decades. In contrast to spontaneous ICH, the duration of bleeding is, 12 to 24 hours in many patients, offering a longer opportunity for Intervention. Treatment varies widely, and optimal therapy has yet to be defined. An OVID search was conducted from January 1996 to January 2006, combining the terms warfarin or anticoagulation with intracranial hemorrhage or intracerebral hemorrhage. Seven experts on clinical stroke, neurologic intensive care, and hematology were provided with the available information and were asked to independently address 3 clinical scenarios about acute reversal and resumption of anticoagulation in the setting of warfarin-associated ICH. No randomized trials assessing clinical outcomes were found on management of warfarin-associated ICH. All experts agreed that anticoagulation should be urgently reversed, but how to achieve it varied from use of prothrombin complex concentrates only (3 experts) to recombinant factor Vila only (2 experts) to recombinant factor Vila along with fresh frozen plasma (1 expert) and prothrombin complex concentrates or fresh frozen plasma (1 expert). All experts favored resumption of warfarin therapy within 3 to 10 days of ICH in stable patients in whom subsequent anticoagulation is mandatory. No general agreement occurred regarding subsequent anticoagulation of patients with atrial fibrillation who survived warfarin-associated ICH. For warfarin-associated ICH, discontinuing warfarin therapy with administration of vitamin K does not reverse the hemostatic defect for many hours and is inadequate. Reasonable management based on expert opinion includes a wide range of additional measures to reverse anticoagulation in the absence of solid evidence. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Mayo Clinic Proceedings
volume
82
issue
1
pages
82 - 92
publisher
Mayo Clinic Proceedings
external identifiers
  • wos:000243230400013
ISSN
0025-6196
language
English
LU publication?
yes
id
296a023c-cc5b-4aaa-ad2b-d2fb538c0768 (old id 679249)
alternative location
http://www.mayoclinicproceedings.com/Abstract.asp?AID=4274&Abst=Abstract&UID=
date added to LUP
2007-12-11 12:43:40
date last changed
2016-09-30 05:50:25
@article{296a023c-cc5b-4aaa-ad2b-d2fb538c0768,
  abstract     = {Wider use of oral anticoagulants has led to an increasing frequency of warfarin-related intracerebral hemorrhage (ICH). The high early mortality of approximately 50% has remained stable in recent decades. In contrast to spontaneous ICH, the duration of bleeding is, 12 to 24 hours in many patients, offering a longer opportunity for Intervention. Treatment varies widely, and optimal therapy has yet to be defined. An OVID search was conducted from January 1996 to January 2006, combining the terms warfarin or anticoagulation with intracranial hemorrhage or intracerebral hemorrhage. Seven experts on clinical stroke, neurologic intensive care, and hematology were provided with the available information and were asked to independently address 3 clinical scenarios about acute reversal and resumption of anticoagulation in the setting of warfarin-associated ICH. No randomized trials assessing clinical outcomes were found on management of warfarin-associated ICH. All experts agreed that anticoagulation should be urgently reversed, but how to achieve it varied from use of prothrombin complex concentrates only (3 experts) to recombinant factor Vila only (2 experts) to recombinant factor Vila along with fresh frozen plasma (1 expert) and prothrombin complex concentrates or fresh frozen plasma (1 expert). All experts favored resumption of warfarin therapy within 3 to 10 days of ICH in stable patients in whom subsequent anticoagulation is mandatory. No general agreement occurred regarding subsequent anticoagulation of patients with atrial fibrillation who survived warfarin-associated ICH. For warfarin-associated ICH, discontinuing warfarin therapy with administration of vitamin K does not reverse the hemostatic defect for many hours and is inadequate. Reasonable management based on expert opinion includes a wide range of additional measures to reverse anticoagulation in the absence of solid evidence.},
  author       = {Aguilar, Maria I. and Hart, Robert G. and Kase, Carlos S. and Freeman, William D. and Hoeben, Maj Barbara J. and Garcia, Rosa C. and Ansell, Jack E. and Mayer, Stephan A. and Norrving, Bo and Rosand, Jonathan and Steiner, Thorsten and Wijdicks, Eelco F. M. and Yamaguchi, Takenori and Yasaka, Masahiro},
  issn         = {0025-6196},
  language     = {eng},
  number       = {1},
  pages        = {82--92},
  publisher    = {Mayo Clinic Proceedings},
  series       = {Mayo Clinic Proceedings},
  title        = {Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion},
  volume       = {82},
  year         = {2007},
}